Safety Study of GPX-150 in Patients With Solid Tumors

Clinical trial NCT00710125 · COMPLETED

Trial details

NCT number: NCT00710125
Sponsor: Gem Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors - Phase 1 Population

Start date: 2008-01-01
Primary completion: 2013-10-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.